Rockville, MD, USA, Aug. 17, 2017 -- The Regulatory Affairs Professionals Society (RAPS) will honor two groups of exemplary regulatory leaders next month at its annual Regulatory Convergence conference, being held at the Gaylord National Resort and Convention Center at National Harbor on the Washington, DC, waterfront 9–12 September. Four outstanding individuals who have had a profound impact on the regulatory profession during their careers will be the inaugural recipients of the Founder’s Award, the profession’s highest honor. Three honorees will be the first-ever recipients of the Community Leadership Award. All awardees were selected by a group of high-level regulatory peers.
|
|||
Founder’s Award recipients have shaped regulatory policy and practice; made a positive impact on the profession through education and mentoring; volunteered time to leadership pursuits such as serving on the RAPS board or Fellows program; promoted healthcare and patient well-being; advanced regulatory agility and raised awareness of the value of regulatory. The 2017 recipients are:
- Susan Alpert, MD, PhD, FRAPS, principal, SFA Consulting LLC
- Junshi Chen, MD, head, International Life Sciences Institute Focal Point, China
- Agnes Klein, MD, senior medical advisor in the Director General’s Office, Health Canada
- Murray “Mac” Lumpkin, MD, deputy director integrated development, Bill & Melinda Gates Foundation
The Community Leadership Award recognizes RAPS members who have built networks and supported regulatory professionals in their communities. Awardees have acted as RAPS ambassadors; engaged in chapter or local activities, including networking and outreach, for at least three years; and partnered with other organizations to further the profession. The 2017 recipients are:
- Kimberly Belsky, senior director, regulatory policy and intelligence, Mallinckrodt Pharmaceuticals
- Jacqueline Monteiro, RAC, director, regulatory affairs, APAC – Dental Platform, KAVO Kerr
- Michelle Ragozzino, PhD, regulatory affairs manager, Cordis Corporation
“The RAPS community is full of extraordinary people who deserve to be celebrated for the way they tie together excellence in their work with a dedication to the RAPS mission,” said Todd Chermak, chairman of the RAPS board of directors, and divisional vice president of Innovation and Development, Abbott Established Pharmaceuticals. “We see the elevation and celebration of leaders in the community as a way to not only recognize those doing exceptional work right now, but also inspire members to spread the mission through a greater level of excellence in the future.”
Awardees will be recognized during the Regulatory Convergence opening plenary session on 10 September.
Reporters, bloggers and other members of the media who wish to cover all or part of the RAPS Regulatory Convergence should contact Zachary Brousseau, senior manager, communications, RAPS, at [email protected] or +1 301 770 2920, ext. 245. On-site registration also will be available for media with valid press credentials or a letter from an assigning editor.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with chapters and affiliates worldwide. www.RAPS.org
###
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/450c3a78-f4a0-480a-870d-66a758c5ab1c
Zachary Brousseau Regulatory Affairs Professionals Society (RAPS) 301 770 2920, ext. 245 [email protected]


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Instagram Outage Disrupts Thousands of U.S. Users
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



